StockData
Beyond Air, Inc. logo

Beyond Air, Inc. (XAIR) shareholders

XAIRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3084% below fair value
$1.85−0.16 (-7.96%)

Close on Nov 18, 2026Market cap $1.77MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
7.2%
0M of 1M shares
Institutional holders
29
5 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $287.35K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Marc Lasry
Joint filing with Avenue Capital Management II, L.P. (8.86%), Avenue Venture Opportunities Fund II, L.P. (5.31%) and 2 more
8,072,8728.86%13G (passive) amendmentDec 31, 2024
Alyeska Fund GP, LLC
Joint filing with Alyeska Investment Group, L.P. (9.90%), Anand Parekh (9.90%)
7,146,5769.90%13G (passive)Dec 31, 2024
Charles Mosseri Marlio3,330,2509.21%13G (passive) amendmentDec 31, 2023
Balyasny Asset Management Holdings LP
Joint filing with Balyasny Asset Management L.P. (9.27%), Bam Gp LLC (9.27%) and 2 more
763,2669.27%13G (passive) amendmentSep 30, 2025
Bam Gp LLC
Joint filing with Balyasny Asset Management L.P. (5.30%), Balyasny Asset Management Holdings LP (5.30%) and 2 more
763,2665.30%13G (passive) amendmentJun 30, 2026
Dames GP LLC
Joint filing with Balyasny Asset Management L.P. (7.25%), Bam Gp LLC (7.25%) and 2 more
763,2667.25%13G (passive) amendmentMar 31, 2026
Anand Parekh
Joint filing with Alyeska Investment Group, L.P. (7.27%), Alyeska Fund GP, LLC (7.27%)
582,6387.27%13G (passive) amendmentDec 31, 2025
Lin Yi-Chien148,0008.90%13G (passive) amendmentOct 12, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of XAIRValueChange% of portfolio
Balyasny Asset Management L.P.23,2082.42%$206.97K–0.00%
Murchinson Ltd.13,7101.43%$122.27K−2,7890.02%
Daytona Street Capital LLC7,5780.79%$61.45K−2650.04%
Geode Capital Management, LLC5,6120.59%$50.05K−2,3600.00%
Bleichroeder LP4,3240.45%$38.57K–0.01%
Vanguard Capital Management LLC3,1370.33%$27.98K+1,5400.00%
Commonwealth Equity Services, LLC2,3690.25%$21.13KNew0.00%
Vanguard Fiduciary Trust Co1,4680.15%$13.10K–0.00%
BlackRock, Inc.1,1020.12%$9.83K–0.00%
StoneX Group Inc.1,0780.11%$9.97KNew0.00%
Hrt Financial LP1,0550.11%$9.00KNew0.00%
XTX Topco Ltd8840.09%$7.88K+2810.00%
Northern Trust Corp8520.09%$7.60KNew0.00%
Wealth Effects LLC8480.09%$7.57K−5700.00%
Baldwin Brothers LLC/Ma7400.08%$6.60K–0.00%
Osaic Holdings, Inc.4060.04%$3.65K–0.00%
Tower Research Capital LLC (TRC)2290.02%$2.04K–0.00%
PFS Partners, LLC1000.01%$892–0.00%
IFP Advisors, Inc570.01%$507–0.00%
NewEdge Advisors, LLC230.00%$204–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026290M7.2%5 / 24 / 40M0M
Q1 2026290M7.3%6 / 19 / 30M0M
Q4 2025270M7.4%5 / 29 / 60M0M
Q3 2025280M8.5%27 / 01 / 00M0M
Q2 202510M0.0%1 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Robert Scott GoodmanChief Executive Officer, Director34,8223.64%Jul 31, 2026
Steven A. LisiCEO and Chairman of the Board, Director3,327,411347.46%Nov 6, 2025
Daniel J. MoorheadChief Financial Officer4,3400.45%Jul 31, 2026
Michael A. GaulChief Operating Officer94,1509.83%Nov 24, 2025
Douglas Quinton LarsonChief Financial Officer27,5482.88%Nov 6, 2025
Yoori LeeDirector12,6541.32%Nov 24, 2025
Robert CareyDirector5,553,490579.92%Nov 7, 2025
Erick LuceraDirector43,6084.55%Nov 6, 2025
William P. ForbesDirector14,8551.55%Nov 6, 2025
Ron BentsurDirector144,73615.11%Nov 26, 2024
Yi-Chien Lin10% owner148,00015.45%Oct 14, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Yi-Chien Lin
10% owner
Oct 13, 2026Buy+2,607$2.21$5.76K148,000
Yi-Chien Lin
10% owner
Oct 1, 2026Buy+15,393$2.80$43.10K145,393
Yi-Chien Lin
10% owner
Sep 30, 2026Buy+2,000$2.71$5.42K130,000
Yi-Chien Lin
10% owner
Sep 29, 2026Buy+3,000$2.69$8.07K128,000
Daniel J. Moorhead
Chief Financial Officer
Jul 29, 2026Buy+4,340$5.76$25.00K4,340
Robert Scott Goodman
Chief Executive Officer, Director
Jul 29, 2026Buy+34,722$5.76$200.00K34,822
Steven A. Lisi
CEO and Chairman of the Board, Director
Jul 21, 2025Buy+6,000$3.25$19.50K3,327,411
Robert Carey
Director
Mar 14, 2025Buy+10,000$0.26$2.60K4,076,864
Robert Carey
Director
Mar 14, 2025Buy+990,000$0.25$247.50K4,066,864
Michael A. Gaul
Chief Operating Officer
Feb 19, 2025Buy+6,000$0.38$2.28K94,150
Robert Carey
Director
Sep 26, 2024Buy+1,476,626$0.50$738.31K1,476,626
Steven A. Lisi
CEO and Chairman of the Board, Director
Sep 26, 2024Buy+1,476,626$0.50$738.31K3,249,411
Steven A. Lisi
CEO and Chairman of the Board, Director
Aug 15, 2024Buy+50,000$0.37$18.50K1,772,785
Erick Lucera
Director
Aug 14, 2024Buy+39,266$0.40$15.71K43,608
Steven A. Lisi
CEO and Chairman of the Board, Director
Aug 14, 2024Buy+100,000$0.39$39.00K1,722,785
Robert Carey
Director
Aug 14, 2024Buy+100,000$0.40$40.00K3,076,864
Robert Carey
Director
Mar 20, 2024Award+602,410$1.66$1.00M2,976,864
Douglas Quinton Larson
Chief Financial Officer
Mar 20, 2024Award+12,048$1.66$20.00K27,548
Steven A. Lisi
CEO and Chairman of the Board, Director
Mar 20, 2024Award+78,314$1.66$130.00K1,614,785
Amir Avniel
Chief Business Officer, Director
Dec 28, 2023Sale−13,733$2.05$28.15K0
Amir Avniel
Chief Business Officer, Director
Dec 28, 2023Sale−11,267$2.06$23.21K685,760
Jeff Lynn Myers
Chief Medical Officer
Dec 27, 2023Sale−3,423$2.21$7.56K46,577
Robert Carey
Director
Dec 18, 2023Buy+1,200,000$1.64$1.97M2,374,454
Steven A. Lisi
CEO and Chairman of the Board, Director
Dec 18, 2023Buy+77,775$1.63$126.77K1,536,471
Michael A. Gaul
Chief Operating Officer
Nov 16, 2023Buy+10,000$1.77$17.70K88,150
Robert Carey
Director
Aug 28, 2023Buy+250,000$2.70$675.00K1,225,160
Robert Carey
Director
Aug 21, 2023Buy+75,050$2.76$207.14K975,160
Robert Carey
Director
Aug 18, 2023Buy+13,614$2.64$35.94K900,110
Michael A. Gaul
Chief Operating Officer
Jun 30, 2023Buy+5,000$4.51$22.55K78,150
William P. Forbes
Director
Mar 31, 2023Buy+5,000$6.67$33.35K14,855
Robert Carey
Director
Mar 30, 2023Buy+10,000$6.45$64.50K886,496
Amir Avniel
Chief Business Officer, Director
Mar 29, 2023Award+240,000––697,027
Robert Carey
Director
Mar 29, 2023Buy+10,000$6.30$63.00K876,496
Yoori Lee
Director
Mar 28, 2023Buy+3,115$6.34$19.75K12,654
Jeff Lynn Myers
Chief Medical Officer
Mar 27, 2023Award+50,000––50,000
Michael A. Gaul
Chief Operating Officer
Mar 24, 2023Buy+1,000$6.15$6.15K73,150
Ron Bentsur
Director
Mar 20, 2023Buy+2,300$6.48$14.90K144,736
Steven A. Lisi
CEO and Chairman of the Board, Director
Mar 17, 2023Buy+10,000$6.46$64.60K1,458,696
William P. Forbes
Director
Mar 17, 2023Buy+5,000$6.46$32.30K9,855
Robert Carey
Director
Mar 16, 2023Gift−28,656––835,840
Erick Lucera
Director
Mar 16, 2023Buy+2,000$6.82$13.64K4,342
Robert Carey
Director
Mar 14, 2023Buy+10,000$6.85$68.50K866,496
Amir Avniel
Chief Business Officer, Director
Mar 13, 2023Buy+1,000$6.40$6.40K457,027
Robert Carey
Director
Mar 13, 2023Buy+4,173$6.15$25.66K856,496
Steven A. Lisi
CEO and Chairman of the Board, Director
Mar 8, 2023Buy+5,000$5.89$29.45K1,447,849
Robert Carey
Director
Mar 8, 2023Buy+10,000$5.95$59.50K852,323
Steven A. Lisi
CEO and Chairman of the Board, Director
Mar 7, 2023Buy+45,000$5.98$269.10K1,442,849
Michael A. Gaul
Chief Operating Officer
Mar 7, 2023Buy+8,000$5.86$46.88K72,150
Steven A. Lisi
CEO and Chairman of the Board, Director
Feb 16, 2023Sale−48,596$6.10$296.44K1,397,849
Robert Carey
Director
Dec 7, 2022Buy+20,000$5.75$115.00K842,323
Robert Carey
Director
Dec 2, 2022Gift−16,000––864,496
Robert Carey
Director
Nov 29, 2022Buy+15,000$5.75$86.25K822,323
Robert Carey
Director
Nov 28, 2022Buy+15,000$5.75$86.25K807,323
Robert Carey
Director
Nov 18, 2022Buy+20,000$5.80$116.00K792,323
Robert Carey
Director
Nov 17, 2022Buy+20,000$5.90$118.00K772,323
Robert Carey
Director
Nov 16, 2022Buy+10,000$6.00$60.00K752,323
Michael A. Gaul
Chief Operating Officer
Aug 22, 2022Buy+2,000$9.42$18.84K64,150
Amir Avniel
COO and President, Director
Jun 30, 2022Sale−2,600$6.57$17.08K13,733
Amir Avniel
COO and President, Director
Jun 30, 2022Sale−65,500$6.50$425.75K408,027
Robert Carey
Director
Jun 30, 2022Buy+175,000$6.45$1.13M742,323

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
7.84%
0M shares short
Days to cover
4.8
At 0M shares a day
Change since last report
+25.8%
From 0M shares
Short volume, 20 days
60.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Beyond Air's stock actually held short. Settlement fails (shares not delivered on time) peaked at 62,277 shares on Sep 1, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Amir Avniel
Officer
Aug 22, 2024180,415$83.44KAug 22, 2024Private placement
Amir Avniel
Director
Dec 29, 202350,000$108.50KDec 28, 2023Private Placement

See a number that looks wrong?